MedImmune Ventures, Inc. 4
4 · G1 Therapeutics, Inc. · Filed Dec 18, 2017
Insider Transaction Report
Form 4
MedImmune Ventures, Inc.
10% Owner
Transactions
- Sale
Common Stock, $0.0001 par value per share
2017-12-15$19.75/sh−200,000$3,950,000→ 2,950,630 total